Topic: Aseem Malhotra

Dr. Aseem Malhotra, a renowned cardiologist and advisor to Robert F. Kennedy Jr., joins the show to discuss his role in the new administration's health initiatives. Malhotra, who initially supported the COVID-19 vaccine, describes how his father's sudden death led him to investigate the harms of mRNA technology. He outlines a "radical plan" to address chronic diseases and reform the HHS.

Dowd notes that COVID booster uptake has failed as more people become aware of potential risks. He addresses rumors of a new "hemorrhagic fever" outbreak, stating he will not comply with future lockdowns or masking. He argues that highly lethal viruses like Ebola are naturally self-limiting because they kill the host too quickly to spread effectively.

Prominent UK cardiologist Dr. Aseem Malhotra has called for the worldwide withdrawal of COVID-19 vaccines following the death of his father. Dr. McCullough notes that only 13% of Americans are taking boosters, suggesting a massive loss of public trust. The discussion concludes with a call for doctors to admit they were "conned" and to prioritize patient safety over establishment narratives.

British cardiologist Dr. Aseem Malhotra has released papers calling for the suspension of mRNA vaccines after observing a rise in unexplained cardiac arrests and heart inflammation. Data from Israel reportedly shows a 25% increase in heart attacks among 16 to 39-year-olds specifically linked to the vaccine rather than COVID-19 infection. Malhotra, who initially promoted the vaccine, now claims that researchers are suppressing negative findings to avoid losing pharmaceutical industry funding.

Dr. Aseem Malhotra discusses research showing a significant increase in heart attack risk markers following vaccination, rising from 11% to 25% over five years. He cites a whistleblower from a British cardiology department who claims researchers are withholding similar findings to protect industry funding. Data from the UK indicates 10,000 excess non-COVID deaths since July, largely driven by circulatory diseases.